Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
MicroRNA-target interaction regulatory network in Alzheimer’s disease
ID
Turk, Aleksander
(
Author
),
ID
Kunej, Tanja
(
Author
),
ID
Peterlin, Borut
(
Author
)
PDF - Presentation file,
Download
(1,38 MB)
MD5: 5EA382DC4A110FE710F81E2FDCD5CA74
URL - Source URL, Visit
https://www.mdpi.com/2075-4426/11/12/1275
Image galllery
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia; however, early diagnosis of the disease is challenging. Research suggests that biomarkers found in blood, such as microRNAs (miRNA), may be promising for AD diagnostics. Experimental data on miRNA–target interactions (MTI) associated with AD are scattered across databases and publications, thus making the identification of promising miRNA biomarkers for AD difficult. In response to this, a list of experimentally validated AD-associated MTIs was obtained from miRTarBase. Cytoscape was used to create a visual MTI network. STRING software was used for protein–protein interaction analysis and mirPath was used for pathway enrichment analysis. Several targets regulated by multiple miRNAs were identified, including: BACE1, APP, NCSTN, SP1, SIRT1, and PTEN. The miRNA with the highest numbers of interactions in the network were: miR-9, miR-16, miR-34a, miR-106a, miR-107, miR-125b, miR-146, and miR-181c. The analysis revealed seven subnetworks, representing disease modules which have a potential for further biomarker development. The obtained MTI network is not yet complete, and additional studies are needed for the comprehensive understanding of the AD-associated miRNA targetome.
Language:
English
Keywords:
Alzheimer’s disease
,
protein–protein interaction (PPI)
,
biomarker
,
microRNA (miRNA)
,
miRNA–target interaction (MTI)
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
BF - Biotechnical Faculty
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
18 str.
Numbering:
Vol. 11, iss. 12, art. 1275
PID:
20.500.12556/RUL-133693
UDC:
616:575
ISSN on article:
2075-4426
DOI:
10.3390/jpm11121275
COBISS.SI-ID:
87716611
Publication date in RUL:
09.12.2021
Views:
1209
Downloads:
170
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of personalized medicine
Shortened title:
J. pers. med.
Publisher:
MDPI
ISSN:
2075-4426
COBISS.SI-ID:
31207641
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
02.12.2021
Secondary language
Language:
Slovenian
Keywords:
medicina
,
Alzheimerjeva bolezen
,
bioinformatika
,
biomarkerji
,
genetika
,
miRNA
,
zunajcelični vezikli
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P3-0326
Name:
Ginekologija in reprodukcija: genomika za personalizirano medicino
Funder:
ARRS - Slovenian Research Agency
Project number:
P4-0220
Name:
Primerjalna genomika in genomska biodiverziteta
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back